Skip to main content
    B

    Baxter International Inc (BAX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $25.55
    -0.26 (-1.03%)

    Market Cap: $13.35B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Baxter International Inc (BAX) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    Baxter International reported revenue of $11.24B for the fiscal year ended Dec 31, 2025, up 5.7% from the year before. That year, net income was -$957.00M with a net margin of -8.5%, operating cash flow was $845.00M and free cash flow was $332.00M. The quarter ended Sep 30, 2026 had revenue of $2.98B and net income of $294.00M.

    Revenue and Margins

    The operating margin was -2.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $10.16B, a compound annual rate of 1.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$11.24B+5.7%30.1%-2.7%-8.5%
    Dec 2024$10.64B+2.7%37.5%0.1%-6.0%
    Dec 2023$10.36B+3.0%40.1%6.8%25.7%
    Dec 2022$10.06B-17.2%35.3%-28.3%-24.1%
    Dec 2021$12.15B+4.1%38.9%11.1%10.7%
    Dec 2020$11.67B+2.7%39.3%13.8%9.5%
    Dec 2019$11.36B+2.4%41.9%15.6%8.9%
    Dec 2018$11.10B+4.9%42.9%14.3%13.9%
    Dec 2017$10.58B+4.1%42.3%12.2%5.7%
    Dec 2016$10.16BN/A40.5%7.3%48.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$11.24B$10.64B$10.36B$10.06B$12.15B$11.67B$11.36B$11.10B$10.58B$10.16B
    Cost of revenue$7.87B$6.65B$6.21B$6.51B$7.43B$7.09B$6.60B$6.34B$6.11B$6.05B
    Gross profit$3.38B$3.98B$4.15B$3.55B$4.72B$4.59B$4.76B$4.76B$4.47B$4.12B
    Research and development$518.00M$590.00M$518.00M$450.00M$531.00M$521.00M$595.00M$654.00M$615.00M$646.00M
    Operating income-$308.00M$14.00M$707.00M-$2.85B$1.35B$1.62B$1.77B$1.58B$1.29B$745.00M
    Net income-$957.00M-$638.00M$2.66B-$2.42B$1.29B$1.11B$1.01B$1.55B$602.00M$4.96B
    EBITDA$714.00M$1.05B$1.67B-$1.78B$2.18B$2.25B$1.83B$2.43B$1.91B$5.82B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$2.98B$2.96B$2.70B$2.97B$2.83B$2.81B$2.63B$2.75B$2.70B$2.69B$2.49B$541.00M
    Gross profit$994.00M$1.03B$891.00M$577.00M$950.00M$991.00M$861.00M$959.00M$1.03B$1.03B$961.00M$708.00M
    Operating income$225.00M$217.00M$66.00M-$729.00M$172.00M$191.00M$58.00M-$435.00M$155.00M$179.00M$115.00M$416.00M
    Net income$294.00M$126.00M-$15.00M-$1.13B-$46.00M$91.00M$126.00M-$510.00M$144.00M-$311.00M$39.00M$246.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $9.48B exceeded cash and equivalents by $7.51B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$20.05B$25.78B$28.28B$28.29B$33.52B$20.02B$18.19B$15.72B$17.11B$15.55B
    Current assets$6.87B$8.85B$9.60B$8.01B$8.87B$8.41B$7.50B$5.96B$7.26B$6.57B
    Cash and equivalents$1.97B$1.76B$3.08B$1.72B$2.95B$3.73B$3.33B$1.84B$3.39B$2.80B
    Total liabilities$13.95B$18.76B$19.81B$22.39B$24.40B$11.29B$10.28B$7.85B$8.00B$7.27B
    Short-term debt$3.00M$2.75B$2.67B$1.40B$511.00M$406.00M$541.00M$4.00M$3.00M$3.00M
    Long-term debt$9.47B$10.37B$11.09B$15.23B$17.15B$5.79B$4.81B$3.48B$3.51B$2.78B
    Shareholder equity$6.13B$6.96B$8.40B$5.83B$9.08B$8.69B$7.88B$7.84B$9.12B$8.29B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$19.41B$19.79B$19.85B$20.05B$21.07B$21.05B$21.30B$25.78B$26.68B$26.31B$27.79B$28.28B
    Total liabilities$12.94B$13.61B$13.83B$13.95B$13.85B$13.75B$14.25B$18.76B$18.73B$18.60B$19.55B$19.81B
    Cash and equivalents$1.98B$2.15B$2.02B$1.97B$1.73B$1.69B$2.29B$1.76B$1.42B$2.10B$3.03B$3.08B
    Shareholder equity$6.50B$6.21B$6.04B$6.13B$7.24B$7.32B$7.08B$6.96B$7.87B$7.64B$8.17B$8.40B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 39.3% of operating cash flow. Dividends came to 104.8% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$845.00M$1.02B$1.73B$1.21B$2.22B$1.87B$2.10B$2.02B$1.71B$1.65B
    Capital expenditures$513.00M$446.00M$432.00M$377.00M$691.00M$709.00M$696.00M$659.00M$616.00M$719.00M
    Free cash flow$332.00M$573.00M$1.29B$834.00M$1.53B$1.16B$1.41B$1.36B$1.10B$935.00M
    Dividends paid$348.00M$590.00M$586.00M$573.00M$530.00M$473.00M$423.00M$376.00M$315.00M$268.00M
    Share repurchasesN/AN/AN/A$32.00M$600.00M$500.00M$1.27B$2.45B$564.00M$292.00M
    Investing cash flow$2.84B-$626.00M$3.21B-$931.00M-$11.20B-$1.18B-$1.10B-$916.00M-$1.29B-$715.00M
    Financing cash flow-$4.22B-$1.08B-$3.49B-$1.44B$8.24B-$345.00M$498.00M-$2.60B$93.00M-$324.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$558.00M$285.00M$213.00M$584.00M$237.00M$217.00M-$193.00M$488.00M$253.00M$115.00M$163.00M$531.00M
    Capital expenditures$110.00M$116.00M$137.00M$140.00M$111.00M$140.00M$122.00M$132.00M$134.00M$70.00M$110.00M$92.00M
    Free cash flow$448.00M$169.00M$76.00M$444.00M$126.00M$77.00M-$315.00M$356.00M$119.00M$45.00M$53.00M$439.00M
    Last 12 quarters

    Frequently Asked Questions About BAX

    What is Baxter International's annual revenue?

    Baxter International reported revenue of $11.24B for the fiscal year ended Dec 31, 2025.

    How fast is Baxter International's revenue growing?

    Revenue was up 5.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 3.8%.

    Is Baxter International profitable?

    No. Baxter International reported net income of -$957.00M for the fiscal year ended Dec 31, 2025, with a net margin of -8.5%.

    How much free cash flow does BAX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $845.00M minus capital expenditures of $513.00M produced free cash flow of $332.00M.

    How much debt does Baxter International have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $9.47B, short-term debt of $3.00M and cash and equivalents of $1.97B.